Chinese University of Hong Kong
Hong Kong
NCT Number: NCT01525732
Spastic esophageal motility disorders induced significant symptoms including dysphagia, retrosternal pain and regurgitation. Per oral endoscopic myotomy (P.O.E.M.) is a novel approach to perform myotomy through the esophagus with long submucosal tunnel. This study aimed to investigate the feasibility and safety of P.O.E.M. and translate the techniques from animal study to clinical practice in human.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Hong Kong
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: From 1st day after POEM to within 2 weeks after POEM
Time frame: Before and 1 month after POEM
Time frame: From Day 1 to until 2 weeks after POEM
Time frame: Up to 24 hours
Time frame: From day of admission till up to 30 days
Time frame: 30 days after operation
Chinese University of Hong Kong
Other
Prospective Study on the Feasibility and Effectiveness of Per-Oral Endoscopic Myotomy (P.O.E.M.) for Treatment of Primary Esophageal Motility Disorders
Acronym: POEM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05772260
Achalasia, Deglutition Disorders
Seoul, South Korea
View Trial DetailsNCT03063463
Achalasia, Deglutition Disorders
Nashville, Tennessee, United States
View Trial DetailsNCT01793922
Achalasia, Deglutition Disorders
Leuven, Belgium
View Trial DetailsNCT01512719
Achalasia, Deglutition Disorders
Jerusalem, Israel
View Trial Details